The innovative drug sector has seen an expanded increase, with Prologis Pharmaceuticals hitting the daily limit.

The innovation drug sector has seen an expanded rise, with Puluo Pharmaceutical hitting the daily limit, and previously, stocks like Ruikang Medicine, Baipusais, Hayao Co., and Haizheng Pharmaceutical also reached their daily limits. BeiDa Pharmaceutical, Haofan Bio, and Haoyuan Medicine have seen significant gains.